SPI Healthcare
3.597,97
PKT
+5,14
PKT
+0,14
%
Werbung
Leider sind zu diesem Wert keine aktuellen Kursdaten verfügbar, die Stammdaten finden Sie im unteren Seitenbereich.
Analysen zu SPI Healthcare-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.06.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 12.06.19 | Roche buy | Goldman Sachs Group Inc. | |
| 05.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 04.06.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 04.06.19 | Novartis Neutral | UBS AG | |
| 03.06.19 | Roche overweight | JP Morgan Chase & Co. | |
| 30.05.19 | Novartis Underweight | Morgan Stanley | |
| 29.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 29.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 28.05.19 | Novartis Neutral | Credit Suisse Group | |
| 28.05.19 | Novartis Conviction Buy | Goldman Sachs Group Inc. | |
| 27.05.19 | Novartis Neutral | UBS AG | |
| 27.05.19 | Novartis Hold | Deutsche Bank AG | |
| 24.05.19 | Novartis Neutral | UBS AG | |
| 24.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.05.19 | Roche overweight | Barclays Capital | |
| 21.05.19 | Novartis buy | Kepler Cheuvreux | |
| 21.05.19 | Roche Hold | Deutsche Bank AG | |
| 17.05.19 | Novartis Neutral | Credit Suisse Group | |
| 16.05.19 | Roche buy | Goldman Sachs Group Inc. | |
| 16.05.19 | Novartis buy | Jefferies & Company Inc. | |
| 16.05.19 | Novartis Neutral | UBS AG | |
| 16.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 09.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 08.05.19 | Roche overweight | JP Morgan Chase & Co. | |
| 07.05.19 | Novartis Hold | Deutsche Bank AG | |
| 07.05.19 | Roche Reduce | Oddo BHF | |
| 06.05.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 30.04.19 | Roche overweight | Morgan Stanley | |
| 25.04.19 | Novartis Neutral | Credit Suisse Group | |
| 25.04.19 | Novartis Hold | Deutsche Bank AG | |
| 25.04.19 | Novartis Hold | HSBC | |
| 25.04.19 | Novartis buy | Jefferies & Company Inc. | |
| 25.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 24.04.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
| 24.04.19 | Novartis Neutral | UBS AG | |
| 24.04.19 | Novartis Underweight | JP Morgan Chase & Co. | |
| 18.04.19 | Roche buy | Jefferies & Company Inc. | |
| 18.04.19 | Roche Neutral | Credit Suisse Group | |
| 18.04.19 | Roche Hold | Deutsche Bank AG |